3.34

0.60% -0.02

After Hours: 3.36 0.02 +0.60%

Anavex Life Sciences Corp (AVXL)

Overview News Price History Option Chain Financials Why AVXL Down? Discussions Forecast Stock Split

Anavex Life Sciences Corp stock is traded at $3.34, with a volume of 1.09M. It is down -0.60% in the last 24 hours and up +12.84% over the past month. Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Previous Close:

$3.36

Open:

$3.25

24h Volume:

1.09M

Relative Volume:

0.78

Market Cap:

$309.52M

Revenue:

Net Income/Loss:

$-39.95M

P/E Ratio:

-7.1843

EPS:

-0.4649

Net Cash Flow:

$-34.08M

1W Performance:

+2.45%

1M Performance:

+12.84%

6M Performance:

-54.86%

1Y Performance:

-59.42%

1-Day Range:

$3.06

$3.355

1-Week Range:

$3.06

$3.50

52-Week Range:

$2.61

$13.99

Anavex Life Sciences Corp Stock (AVXL) Company Profile

Name

Anavex Life Sciences Corp

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

844-689-3939

Address

630 5TH AVENUE, NEW YORK

Employee

Twitter

@anavexlifesci

Next Earnings Date

2026-05-12

Latest SEC Filings

AVXL's Discussions on Twitter

Compare AVXL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVXL Anavex Life Sciences Corp	3.34	311.38M	0	-39.95M	-34.08M	-0.4649
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-23-22	Initiated	Berenberg	Buy
Sep-23-21	Initiated	BTIG Research	Buy
Dec-16-20	Reiterated	H.C. Wainwright	Buy
Sep-28-20	Initiated	Ladenburg Thalmann	Buy
Feb-27-20	Initiated	Cantor Fitzgerald	Overweight
Jun-18-19	Initiated	Janney	Buy
May-16-18	Resumed	Maxim Group	Buy
Mar-08-18	Initiated	ROTH Capital	Buy
Feb-13-18	Reiterated	Maxim Group	Buy
Sep-29-17	Resumed	Noble Financial	Buy
Feb-07-17	Initiated	Noble Financial	Buy
Mar-29-16	Initiated	FBR Capital	Outperform

View All

Anavex Life Sciences Corp Stock (AVXL) Latest News

12:58 PM

Anavex Life Sciences Appoints Terrie Kellmeyer as Interim CEO Following Christopher Missling’s Departure - Minichart

12:58 PM

10:52 AM

CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus - Yahoo Finance

10:52 AM

10:29 AM

Anavex stock slips after CEO transition (AVXL:NASDAQ) - Seeking Alpha

10:29 AM

08:10 AM

Anavex Life Sciences Names Interim CEO Amid Leadership Shift - TipRanks

08:10 AM

07:19 AM

Anavex appoints interim CEO following leadership change By Investing.com - Investing.com Canada

07:19 AM

07:04 AM

CEO ousted as Anavex (NASDAQ: AVXL) board installs interim chief and eyes 10-Q delay - Stock Titan

07:04 AM

May 04, 2026

H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com Australia

May 04, 2026

H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com

May 04, 2026

May 02, 2026

MSN Money - MSN

May 02, 2026

May 01, 2026

Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan

May 01, 2026

AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill

May 01, 2026

Apr 30, 2026

Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat

Apr 30, 2026

AVXL stock soars after Anavex’s new data suggests its Alzheimer’s drug may slow brain shrinkage - MSN

Apr 30, 2026

Apr 28, 2026

Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN

Apr 28, 2026

Apr 26, 2026

Anavex stock slides after hours on EMA panel’s negative Alzheimer’s drug opinion — retail traders talk buyout potential - MSN

Apr 26, 2026

What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks - Yahoo Finance

Apr 26, 2026

Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN

Apr 26, 2026

Apr 22, 2026

Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat

Apr 22, 2026

Apr 18, 2026

Anavex (AVXL) Stock: Buy or Sell? (+7.06%) 2026-04-18High Interest Stocks - Xã Vĩnh Công

Apr 18, 2026

Apr 16, 2026

AVXL | Anavex Life Sciences Insider Trading - Quiver Quantitative

Apr 16, 2026

Apr 15, 2026

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology between Autism and Alzheimer's disease - marketscreener.com

Apr 15, 2026

Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference - MarketBeat

Apr 15, 2026

Apr 14, 2026

Anavex Life Sciences Advances Blarcamesine Research, Highlighting Shared Autophagy Mechanisms in Autism and Alzheimer’s Disease - Quiver Quantitative

Apr 14, 2026

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease - marketscreener.com

Apr 14, 2026

Autistic adults had up to 8x dementia rates in research Anavex cites - Stock Titan

Apr 14, 2026

Anavex links autism and Alzheimer’s via autophagy dysfunction - Investing.com

Apr 14, 2026

Apr 12, 2026

Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire

Apr 12, 2026

Apr 11, 2026

Aug Rallies: Does Anavex Life Sciences Corp have strong fundamentalsMarket Activity Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn

Apr 11, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 10, 2026

AVXL Technical Analysis | Trend, Signals & Chart Patterns | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill

Apr 10, 2026

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

AVXL Q1 2026 Earnings: Anavex Life Sciences beats EPS ests, no revenueConsensus Forecast - UBND thành phố Hải Phòng

Apr 08, 2026

Apr 07, 2026

Aug Retail: Is Anavex Life Sciences Corp stock trending bullish2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn

Apr 07, 2026

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times

Apr 07, 2026

Anavex Life Sciences Corp. to Present at 25th Annual Needham Virtual Healthcare Conference - Quiver Quantitative

Apr 07, 2026

Apr 06, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Apr 06, 2026

Apr 05, 2026